HER2 positive early breast cancer: 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
Clinical trial results published by our Clinical Trials Unit show that women treated with 6 months of Herceptin for HER2 positive early breast cancer did as well in terms of their risk of breast cancer returning as those getting the currently conventional 12 months treatment.
Patients can assess their own back pain using an app on their phone or tablet as effectively as current paper methods, a new study from Warwick Medical School has shown.
Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds
A new study funded by Cancer Research UK and sponsored by the University of Warwick has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.
Nearly a third of UK adults (30%) wouldn’t perform CPR if they saw someone suffer a cardiac arrest, according to worrying new figures released to mark Restart a Heart Day
Using adrenaline in cardiac arrests results in less than 1% more people leaving hospital alive - but nearly doubles the survivors’ risk of severe brain damage
A clinical trial of the use of adrenaline in cardiac arrests led by Warwick Clinical Trials Unit has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.
As the FIFA World Cup approaches researchers at WMS have found that keyhole surgery could help get injured footballers back on the pitch faster than physiotherapy-led treatments.
Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism
Research led by Professor Annie Young indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.
A delegation from Thailand’s Ministry of Public Health visited the University of Warwick on the 8th March to learn about healthcare in the UK and find out about how the NHS tackles population health within the NHS.
Warwick Medical School is leading a project to help unemployed people with long term pain conditions back into work.
Dr Shreeya Tewary, Obstetrics and Gynaecology Registrar based in the Division of Biomedical Sciences at Warwick Medical School, has been shortlisted for a Tommy’s Award presented by baby charity Tommy’s.
Members of the public and Warwick researchers came together this week to discuss key questions related to cancer research.
The realities of implementing alternatives to face-to-face GP consultations, such as telephone, email, online and video consultations, mean that hoped-for reductions in GP workload and increases in available appointments for patients might not be realised according to a study led by Helen Atherton of Warwick Medical School.
A study led by researchers at Warwick Medical School could help thousands of headache sufferers by investigating whether a new education and self-management programme will help improve their quality of life.
Warwick Medical School is starting a trial to improve the lives of long-term strong painkiller users.
Congratulations to the Warwick Clinical Trials Unit PARAMEDIC2 Trial Team, who have won the West Midlands Clinical Research Network (CRN) Team of the Year Award for greatest contribution to research in the West Midlands.
Professor Gavin Perkins will become the new Director of Warwick Clinical Trials Unit (CTU) from 1 October 2017. He was appointed after an international search and it is a source of great pride for us that Gavin, who is already an established member of CTU, was the best candidate for this key post in the Medical School.
The University of Warwick is to receive more than £7 million to find better ways of delivering healthcare to some of the world’s poorest people.
Warwick Medical School were delighted to host the annual Society for Academic Primary Care conference on the 12th, 13th and 14th July in the Ramphal Building.
A researcher from Warwick Medical School is one of a European team who have developed an online tool and an app for predicting the chance of women developing persistent pain after breast cancer surgery.
Researchers at WMS have opened a window of opportunity for physiotherapists to influence future investigations into fragility fractures in people over 60.
Prof Gavin Perkins has been published in NEJM for his paper on Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis.
How is a Warwick Clinical Trial and Strictly Come Dancing connected?
Well done to the MAMMO 50 trial team who have successfully randomised 2500 patients. This target takes them to the halfway stage!